{"name":"iX Biopharma Ltd.","slug":"ix-biopharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Wafermine","genericName":"Wafermine","slug":"wafermine","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Wafermine","genericName":"Wafermine","slug":"wafermine","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOdmoxT1pnXzNzM3QwamxtVHg3dXlsVjZFR2g2dkVFaXZBQmcyZWxPY2VDckR5TjFza3VTTFhGUkw5bWczYmx0TkFFNHNRTkhZQjBBRmQ5SWpkM0kzUWpBd1dPLTBEdWNKMnBnc1luRUhhQXVpUXFQdS1XdE1FY2tYemk4UkNhblpXMDJwNS1fYzZFMlhnMlFxekk0cUNlcFJPeUJiRDA5NVotRVVyTE5neTdqVzIyTlNON01WamgzWWhaTGMyTVlCcnd5YmxiUDViZHlCdk5RenBMdw?oc=5","date":"2026-04-06","type":"pipeline","source":"Minichart","summary":"iX Biopharma: Innovative WaferiX Sublingual Drug Delivery, US Expansion & Telehealth Growth Strategy 2026 - Minichart","headline":"iX Biopharma: Innovative WaferiX Sublingual Drug Delivery, US Expansion & Telehealth Growth Strategy 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPS1FWQzdZWno3S2MzeEl1d1lMMUlwVV9lVW5ZZnlqcDNGYUpGLWtoLWpsV09mSEg5UFNNTmVLbHdvR09hcFlnZGFoSW10UEtzZW5QU2RQTU9JMlJNT3hRMnQxVE5CMEZuNWlaaDZMS0RkbGhLR05rMktDV01xSUtUYUtfYXUwSHJRV3c?oc=5","date":"2026-02-20","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Danaher, Johnson & Johnson, Bayer and more - Medical Marketing and Media","headline":"Rx Rundown: Danaher, Johnson & Johnson, Bayer and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQSFlZaVN1eWFzSmkzWTh0b1lhUGc0am8zaXhseDROYUIzc2R2RmZYSzVYUlkwSHJWYVdiVDFsN2I3VTFDSHhOMHozaDFxNHVUQjNYbjhzVW51ZjdaT1pXUXdUZl9QYVNmM1NJUkxuMDduVUlrTk9QRm0tUmxRZjFmLW1Sak9aOURVMjIyUHpNdlc2UkhRalZBaHBxR1JqTnk4dnlUTzFoRWZyY1pxbl9yS2hFX0dhelE4d2tIVk52amlMNWF3SHhobEhzY2lHdk42V1ptS2s5R3NJZHZHcWdLdkxUSUpYMXNoTGc?oc=5","date":"2026-02-16","type":"pipeline","source":"BioSpectrum Asia","summary":"Singapore's iX Biopharma secures $41 M contract from US govt for development of non-opioid pain treatment - BioSpectrum Asia","headline":"Singapore's iX Biopharma secures $41 M contract from US govt for development of non-opioid pain treatment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-10","type":"pipeline","source":"simplywall.st","summary":"3 Asian Penny Stocks With Market Caps Under US$1B - simplywall.st","headline":"3 Asian Penny Stocks With Market Caps Under US$1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNa0RFY0pNU040UWR3dzNWelk5NzBmSi03MFJPMGxFM0tkdjlZRUdyTnQzUmpnNHdGWk41LTAzWXZtdVJtdklrMnVMeXBraVk5Zm9tZkZfNVh3UzlEaGwxRGx1bURYRjNzdGZ6dWE0Z29Ba0FpejViSFgxZ3YySWVES3U2eGdzRG1KRTl1OENFQ3JhdGhYU1RhSmtZYnRpcWF5WWRGOExCdEszUWEzNXQ0OUEydHBpS283VVdqbVNkNHB5SzNX?oc=5","date":"2026-01-20","type":"pipeline","source":"TipRanks","summary":"iX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List - TipRanks","headline":"iX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQeURIV0d4TGt5RHh6XzhBZW1BbHJLQkpscWtlekZMSnRib2pBd2VKTWo4dGl0WkNGWUNkT3pObDc3RmQzY1lucEhJYjhmSHlXUmwxc18wck1GSUVveDYzN0lackwzSWNidFF6TzlQYlZNdkM2OEVmVEF1Q21SeW53YVZXSlJiM0xqQkppbGtqaW8xcmRNOUFUTmJvYmRCRTdjWlg0SzdnOWE2ZnFiTGxuWE5ZUm8tTFU?oc=5","date":"2026-01-20","type":"patent","source":"The Straits Times","summary":"Drug delivery patent fuels iX Biopharma's growth - The Straits Times","headline":"Drug delivery patent fuels iX Biopharma's growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ3FkWG9mSHVvZUFPN0UwdzFHcGhTVmFPTzJ5dkZZQWhJdDRHUXMwQXYwSDR4eUIxUFJXRDlEOGRMMkt4VXpvTWNiMXM5WTZOUUs3S0ZFb1d6LWpyN2pCSWNRMnpxZU1jYURMNFlrdE5zUDloR3dOWkdadnFZQnNsSg?oc=5","date":"2025-12-31","type":"pipeline","source":"Yahoo Finance","summary":"iX Biopharma Ltd.'s (Catalist:42C) most bullish insider, CEO Yip Hang Lee must be pleased with the recent 15% gain - Yahoo Finance","headline":"iX Biopharma Ltd.'s (Catalist:42C) most bullish insider, CEO Yip Hang Lee must be pleased with the recent 15% gain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNR2lfQkd0SVp3NlRrTURldTB2N2dLY3l4V0E4VFIwUnE2aTJvNnV0NkJOUGFFc1VQMUNwMjBCMjJsZ1F2Q2JSRVV2ZVZyYVFtbzIwT0N0eGlfQkpEZklqeVZjVExhamlGWXp2ejdZTURTZi1IVDJES3RSOHVXMkpheVZRcVdaOXotelhSNU5iejRTdzVhbGxBZF9DaUptQmY0OC1xQXJNZmZ4M0l4M1NnYw?oc=5","date":"2025-11-10","type":"deal","source":"Singapore Business Review","summary":"iX Biopharma accelerates WaferiX portfolio commercialisation with Orion Labs deal - Singapore Business Review","headline":"iX Biopharma accelerates WaferiX portfolio commercialisation with Orion Labs deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUk1fd0xuTmFYRFNfdXdYNkFvRW5seVZlQ0tUdFNNVVB5aXBxOWJaRkN6TXE2dEpWbzRqYUJ2dndJQWJDWW8ycnBSRVo3NkRPNjBxSzFtQTBOV2tVZHNuMGhXelhOMmpoWFVwQUlWU0VWM0xFRC1fSlptUWEtbU9WdnRzeFJ1enoxZFBIeHluM29iUmd0SzQ5OVl5a2thRmxrSlVfcFhiVHIybGFn?oc=5","date":"2025-10-29","type":"pipeline","source":"The Business Times","summary":"iX Biopharma raises gross proceeds of S$6.7 million from placement - The Business Times","headline":"iX Biopharma raises gross proceeds of S$6.7 million from placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNUWNQczhQaXAxemh1bFZHWW1vM1JyanZZWWhYZU0zOWVKUFFoM0IwVF80YW9FUi1jZjlUZGtPVkl1ZFVuSzh5Ny1TYk5WWk9yNGUxVUhJSWMwOEhMVW4wS0JkWmtYSFdfbFViVW1icmhDeXNQMEhVaTBRMGNKb094OXZrbnMzdmZDZTEyMlc1R3diOEp6Umg0QUgxZ2lfUDJTX1FoajFyT0pMc3psdzJYbDhyYk5Zdw?oc=5","date":"2025-10-27","type":"pipeline","source":"The Business Times","summary":"iX Biopharma shares jump 35% on potential US, Australia listing plans - The Business Times","headline":"iX Biopharma shares jump 35% on potential US, Australia listing plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQejVOQWEzZlFvQV9sYlB3ZkpsbC1MdVk2aDBLa2gxOVF2S3RiT0dHUURIOWc3VVUzWGgyNHVOUVFfVW5WYmdiNlYtdVp0M2k3M25Rb2JldERDQTZnVGhiSUZveDlGOGRRdVB4cHhIRWNwXzRtU0YyeHlZWW5YeHB3WjBwWVhBY1pWT09oek1heGhzNnVuMHVibGl6Vy03YUk?oc=5","date":"2025-09-09","type":"pipeline","source":"BioWorld News","summary":"Biopharma IPO activity slows, but 2025 returns are surging - BioWorld News","headline":"Biopharma IPO activity slows, but 2025 returns are surging","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}